These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32661337)

  • 1. Clinical features and outcomes of IgG4-related idiopathic orbital inflammatory disease: from a large southern China-based cohort.
    Chen J; Zhang P; Ye H; Xiao W; Chen R; Mao Y; Ai S; Liu Z; Tang L; Yang H
    Eye (Lond); 2021 Apr; 35(4):1248-1255. PubMed ID: 32661337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of IgG-4-ROD on the diagnosis of orbital tumors: A retrospective analysis.
    Andron A; Hostovsky A; Nair AG; Sagiv O; Schiby G; Simon GB
    Orbit; 2017 Dec; 36(6):359-364. PubMed ID: 28829660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes and pathological characteristics of immunoglobulin G4-related ophthalmic disease versus orbital inflammatory pseudotumor.
    Min HK; Lee YS; Yang SW; Lee J; Kwok SK; Ju JH; Kim WU; Park SH
    Korean J Intern Med; 2019 Jan; 34(1):220-226. PubMed ID: 29050463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopsy-proven recurrence of unilateral IgG4-related orbital inflammation after 20 years.
    Heidari P; Verdijk RM; van den Bosch WA; Paridaens D
    Orbit; 2014 Oct; 33(5):388-91. PubMed ID: 24911364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG4-related Ophthalmic Disease in Idiopathic Sclerosing and Non-Sclerosing Orbital Inflammation: A 25-Year Experience.
    Tsai CY; Kuo KT; Cheng AMS; Wei YH; Chang HC; Chang K; Liao SL
    Curr Eye Res; 2019 Nov; 44(11):1220-1225. PubMed ID: 31154852
    [No Abstract]   [Full Text] [Related]  

  • 6. High prevalence of IgG4-related lymphoplasmacytic infiltrative disorder in 25 patients with orbital inflammation: a retrospective case series.
    Deschamps R; Deschamps L; Depaz R; Coffin-Pichonnet S; Belange G; Jacomet PV; Vignal C; Benillouche P; Herdan ML; Putterman M; Couvelard A; Gout O; Galatoire O
    Br J Ophthalmol; 2013 Aug; 97(8):999-1004. PubMed ID: 23759440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG4-related disease in patients with idiopathic orbital inflammation syndrome: data from the French SIOI prospective cohort.
    Abad S; Martin A; Héran F; Cucherousset N; Mouriaux F; Héron E; Sédira N; Zmuda M; Groh M; Abbas A; Saadoun D; Aucouturier P; Vicaut E; Dhote R;
    Acta Ophthalmol; 2019 Jun; 97(4):e648-e656. PubMed ID: 30421562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes of IgG4-Related Ophthalmic Disease and Idiopathic Sclerosing Orbital Inflammation.
    Son KY; Woo KI; Kim YD
    Ophthalmic Plast Reconstr Surg; 2022 Jan-Feb 01; 38(1):34-39. PubMed ID: 33782329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD.
    Andrew NH; Sladden N; Kearney DJ; Selva D
    Br J Ophthalmol; 2015 Mar; 99(3):376-81. PubMed ID: 25185258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG4-Related Ophthalmic Disease. Part II: Clinical Aspects.
    McNab AA; McKelvie P
    Ophthalmic Plast Reconstr Surg; 2015; 31(3):167-78. PubMed ID: 25564258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG4-related disease in idiopathic sclerosing orbital inflammation.
    Sa HS; Lee JH; Woo KI; Kim YD
    Br J Ophthalmol; 2015 Nov; 99(11):1493-7. PubMed ID: 25947555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive Orbital Radiotherapy for Ocular Adnexal IgG4-related Disease: Preliminary Experience in Patients Refractory or Intolerant to Corticosteroid Therapy.
    Lin YH; Yen SH; Tsai CC; Kao SC; Lee FL
    Ocul Immunol Inflamm; 2015 Apr; 23(2):162-7. PubMed ID: 25010381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG4 and IgE co-positive group found in idiopathic orbital inflammatory disease.
    Zhao PX; Adzavon YM; Ma JM; Shang L; Chen DY; Xie F; Liu MY; Zhang X; Lyu BB; Zhang MZ; Yang LQ; Ma XM
    Int J Ophthalmol; 2018; 11(1):36-42. PubMed ID: 29375988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital inflammation with IgG4-positive plasma cells: manifestation of IgG4 systemic disease.
    Plaza JA; Garrity JA; Dogan A; Ananthamurthy A; Witzig TE; Salomão DR
    Arch Ophthalmol; 2011 Apr; 129(4):421-8. PubMed ID: 21482868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IgG2 and tissue IgG2 plasma cell elevation in orbital IgG4-related disease (IgG4-RD): Potential use in IgG4-RD assessment.
    Chan ASY; Mudhar H; Shen SY; Lang SS; Fernando M; Hilmy MH; Guppy NJ; Rennie I; Dunkley L; Al Jajeh I
    Br J Ophthalmol; 2017 Nov; 101(11):1576-1582. PubMed ID: 28351925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ophthalmic involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 573 patients.
    Gan L; Luo X; Fei Y; Peng L; Zhou J; Li J; Lu H; Liu Z; Zhang P; Liu X; Zhang W
    BMC Ophthalmol; 2021 Dec; 21(1):447. PubMed ID: 34961492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review.
    Wallace ZS; Deshpande V; Stone JH
    Semin Arthritis Rheum; 2014 Jun; 43(6):806-17. PubMed ID: 24513111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single Institutional Experience on Orbital Inflammatory Pseudotumor: Diagnostic and Management Challenge.
    Derakhshandeh R; Dimopoulos YP; Goodglick TA; Chanine J; Sabet S; Özdemirli M
    Balkan Med J; 2021 Jul; 38(4):239-243. PubMed ID: 34274913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular adnexal IgG4-related disease: clinical features, outcome, and factors associated with response to systemic steroids.
    Yu WK; Kao SC; Yang CF; Lee FL; Tsai CC
    Jpn J Ophthalmol; 2015 Jan; 59(1):8-13. PubMed ID: 25373451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for extraophthalmic involvement and treatment outcomes in patients with IgG4-related ophthalmic disease.
    Park J; Lee MJ; Kim N; Kim JE; Park SW; Choung HK; Khwarg SI
    Br J Ophthalmol; 2018 Jun; 102(6):736-741. PubMed ID: 28972022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.